United Parcel Service Inc. has added a new board member to help bolster its push into health-care services.
UPS appointed long-time Pfizer executive Angela Hwang to its board, effective immediately. Hwang, 54, is a member of Pfizer’s executive team and is Group President of the Pfizer Biopharmaceuticals Group, which comprises approximately 80% of Pfizer’s revenues, according to a UPS news release. In that role, she leads more than 26,000 employees and is responsible for bringing over 600 innovative medicines and products to patients around the world.
Her appointment brings the total number of UPS directors to 13. She is joining the Board’s Audit Committee.
David Abney, UPS executive chairman, said the board engaged in a "thorough search and evaluation" to find the right candidate for the role.
“Angela’s expertise in the health-care sector will bring added talent to our Board as we oversee the company’s strategic growth efforts in this area," he said.
The appointment comes seven weeks into Carol Tomé's transition as the company's new CEO. Tomé, the former executive vice president and CFO of The Home Depot, has been a member of the UPS Board of Directors since 2003 and serves as chairperson of the Audit Committee. She cited the importance of Huang's leadership experience in the health-care logistics space, which has been an area of major expansion for UPS of late. That expansion includes collaborating with public sector entities to provide supply chain services nationwide in response to the Covid-19 pandemic, and also contracting with health-care companies like Henry Schein Inc., McKesson Corp. and DuPont for coronavirus support.
UPS's board previously elected William R. Johnson, an independent director, to serve as chairman upon Abney’s resignation as executive chairman on Sept. 30.